VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.6779
+0.0013 (0.19%)
At close: May 21, 2026, 4:00 PM EDT
0.6775
-0.0004 (-0.06%)
After-hours: May 21, 2026, 7:53 PM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $22.59 million as of May 21, 2026. Its market cap has increased by 8.41% in one year.
Market Cap
22.59M
Enterprise Value
-2.34M
1-Year Change
8.41%
Ranking
Category
Stock Price
$0.68
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $22.59M, a decrease of -90.17%. That is a compound annual growth rate of -31.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 22.59M | 16.99% |
| Dec 31, 2025 | 19.31M | -60.93% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Skye Bioscience | 25.11M |
| Jasper Therapeutics | 24.43M |
| Marker Therapeutics | 23.84M |
| Polyrizon | 23.68M |
| Sensei Biotherapeutics | 23.54M |
| Pluri | 23.12M |
| Traws Pharma | 22.57M |
| AEON Biopharma | 21.60M |